BIOCRYST PHARMACEUTICALS INC (BCRX)

US09058V1035 - Common Stock

5.82  +0.17 (+3.01%)

After market: 5.8 -0.02 (-0.34%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2023-9-30)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
317.56M270.80M157.20M17.80M48.80M
Cost Of Goods
5.53M6.60M7.30M1.70M4.10M
Gross Profit
312.04M264.20M149.90M16.10M44.70M
Operating Expenses
419.37M412.70M327.60M190.90M144.20M
Research and Development
219.73M253.30M208.80M123.00M107.10M
Selling, General, and Administrative Expenses
199.67M159.40M118.80M67.90M37.10M
Operating Income
-107.35M-148.40M-177.70M-174.80M-99.50M
Interest Income/Expense
-98.16M-95.90M-59.90M-6.00M-9.40M
Non Recurring Items
N/A0.0055.80M-2.00MN/A
Income Before Taxes
-234.54M-244.40M-181.80M-182.80M-108.90M
Income Tax
1.82M2.70M2.30MN/AN/A
Net Income
-236.35M-247.10M-184.10M-182.80M-108.90M
EBITDA
-105.72M-146.96M-176.92M-174.05M-98.78M
 
Per Share Data
EPS Diluted Total Ops
-1.25-1.33-1.03-1.09-0.94
Non GAAP EPS
-1.09-1.33-1.03-1.08-0.98
 
Statistics
Gross Profit Margin
98.26%97.56%95.36%90.45%91.60%
Profit Margin
-74.43%-91.25%-117.11%-1026.97%-223.16%
Operating Profit Margin
-33.80%-54.80%-113.04%-982.02%-203.89%

All data in USD

Charts